Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Citigroup analyst Joanne Wuensch upgrades Integra Lifesciences (NASDAQ:IART) from Sell to Neutral and maintains the price ta...
Integra LifeSciences Holdings Corporation (NASDAQ:IART), today announced MicroMatrix® Flex is now available commercially in the...
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price tar...
JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...
Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...
